
Deals this week: Bone Biologics, Thermo Fisher Scientific, TopRidge Pharma
US-based orthobiologic product developer Bone Biologics has announced the signing of an option agreement with University of California, Los Angeles (UCLA), to license the use of bone growth factor Nell-1 in the treatment of osteoporosis.